Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
LPS-EB Biotin Leishmania Lipophosphoglycan Triggers Caspase-11 and the Non-canonical Activa... 2019 Cell Rep. de Carvalho R.V.H. et al. DOI: 10.1016/j.celrep.2018.12.047
Primocin® Correlation of in vitro cell adhesion, local shear flow and cell density. 2019 RSC Adv. Jötten A.M. et al. DOI: 10.1039/C8RA07416J
Plasmocin® - Mycoplasma Elimination Reagent Automated Detection of Autophagy Response Using Single Cell-Based Microscopy ... 2019 Methods Mol Biol. Mueller A.J. & Proikas-Cezanne T. DOI: 10.1007/978-1-4939-8873-0_27
PlasmoTest™ - Mycoplasma Detection Kit SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target. 2019 Nat Commun. Yuan S. et al. DOI: 10.1038/s41467-018-08015-x
Puromycin The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism a... 2019 Oncogene Parzych K. et al. DOI: 10.1038/s41388-018-0651-z
EndoFit™ OVA protein Corn-derived alpha-D-glucan nanoparticles as adjuvant for intramuscular and i... 2019 Nanomedicine. Dhakal S. et al. DOI: 10.1016/j.nano.2018.12.003
R848 (Resiquimod) Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... 2019 Biomacromolecules. Lynn GM. et al. DOI: 10.1021/acs.biomac.8b01473
Imiquimod (R837) Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... 2019 Biomacromolecules. Lynn GM. et al. DOI: 10.1021/acs.biomac.8b01473
QUANTI-Blue™ Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... 2019 Biomacromolecules. Lynn GM. et al. DOI: 10.1021/acs.biomac.8b01473
Human TLR7 Reporter HEK293 Cells (NF-κB) Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... 2019 Biomacromolecules. Lynn GM. et al. DOI: 10.1021/acs.biomac.8b01473
Imiquimod VacciGrade™ (R837) Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... 2019 Biomacromolecules. Lynn GM. et al. DOI: 10.1021/acs.biomac.8b01473
Normocin™ - Antimicrobial Reagent Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... 2019 Biomacromolecules. Lynn GM. et al. DOI: 10.1021/acs.biomac.8b01473
R848 VacciGrade™ Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... 2019 Biomacromolecules. Lynn GM. et al. DOI: 10.1021/acs.biomac.8b01473
ASC-GFP Reporter Monocytes The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... 2019 Mol Cell. Mehto S. et al. DOI: 10.1016/j.molcel.2018.11.018
Poly(I:C) (LMW) / LyoVec™ The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... 2019 Mol Cell. Mehto S. et al. DOI: 10.1016/j.molcel.2018.11.018
MSU Crystals The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... 2019 Mol Cell. Mehto S. et al. DOI: 10.1016/j.molcel.2018.11.018
ATP The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... 2019 Mol Cell. Mehto S. et al. DOI: 10.1016/j.molcel.2018.11.018
Bafilomycin A1 The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... 2019 Mol Cell. Mehto S. et al. DOI: 10.1016/j.molcel.2018.11.018
MDP The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... 2019 Mol Cell. Mehto S. et al. DOI: 10.1016/j.molcel.2018.11.018
Poly(dA:dT) The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... 2019 Mol Cell. Mehto S. et al. DOI: 10.1016/j.molcel.2018.11.018

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty